Imidazo (1, 2-A) pyridine compounds as VEGF-R2 inhibitors

Details for Australian Patent Application No. 2006216710 (hide)

Owner Eli Lilly and Company

Inventors Clayton, Joshua Ryan; Heath, Perry Clark; Barda, David Anthony; Wang, Zhao-Qing; Yip, Yvonne Yee Mai; Henry, James Robert; Mclean, Johnathan Alexander; Knobeloch, John Monte; Zhong, Boyu; Burkholder, Timothy Paul; Hao, Yan; Remick, David Michael; Mendel, David; Rempala, Mark Edward

Agent Spruson & Ferguson

Pub. Number AU-B-2006216710

PCT Pub. Number WO2006/091671

Priority 60/655,981 24.02.05 US

Filing date 23 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 11 August 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375 (2006.01)

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/091671 Priority application(s): WO2006/091671

11 August 2011 Application Accepted

  Published as AU-B-2006216710

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216713-PGD2 receptor antagonists for the treatment of inflammatory diseases

2006216709-Wearable insect repelling patch